Study in Patients With Asthma
NCT00215371 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2010-11-11
Summary
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control group.
Conditions
Interventions
- DRUG
-
Formoterol Fumarate
Sponsors & Collaborators
-
Dey
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 5 Years
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
- Primary Completion
- 2002-10-31
- Completion
- 2005-11-30
Countries
- United States
Study Locations
More Related Trials
-
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
NCT03086460 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients
NCT02415179 ·Status: COMPLETED ·Phase: NA
-
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
NCT00583947 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
NCT00393991 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Mild Asthmatic Patients
NCT00748306 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
NCT00394199 ·Status: COMPLETED ·Phase: PHASE3
-
Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol
NCT02491970 ·Status: TERMINATED ·Phase: PHASE4
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
NCT01785901 ·Status: COMPLETED
-
Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)
NCT00073177 ·Status: COMPLETED ·Phase: PHASE3
-
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
NCT00517816 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474 ·Status: COMPLETED
-
Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
NCT02811315 ·Status: WITHDRAWN
-
A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma
NCT00862394 ·Status: COMPLETED ·Phase: PHASE3
-
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
NCT01537133 ·Status: COMPLETED ·Phase: NA
-
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
NCT01502371 ·Status: COMPLETED ·Phase: PHASE2
-
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
NCT00358488 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Repeat Dose Safety Study for Compound to Treat Asthma
NCT01202214 ·Status: COMPLETED ·Phase: PHASE1